Bacterial colicin-immunity protein protein purification system
US-2024417426-A1 · Dec 19, 2024 · US
Anti-bacterial peptides and methods of treating diseases using same
US9012152B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9012152-B2 |
| Application number | US-52254508-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 8, 2008 |
| Priority date | Jan 9, 2007 |
| Publication date | Apr 21, 2015 |
| Grant date | Apr 21, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Isolated peptides comprising no more than ten amino acids and having anti-bacterial properties are disclosed. In one embodiment the peptides have a consensus amino acid sequence X 1 X 2 X 3 X 4 X 5 , wherein X 1 and X 5 comprise polar amino acids. In another embodiment, the peptides have a consensus amino acid sequence X 1 X 2 X 3 X 4 X 5 , wherein X 2 and X 4 are asparagine (N) residues and X 3 is tryptophan (W). Compositions comprising same are also disclosed and uses thereof.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of killing bacteria which comprise the mazEF toxin-antitoxin module and which are in logarithmic growth, the method comprising contacting the bacteria with an effective amount of an isolated pentapeptide, comprising a consensus amino acid sequence X 1 X 2 X 3 X 4 X 5 , wherein both X 1 and X 5 comprise an amino acid independently selected from the group consisting of an asparagine residue and a glutamine residue wherein X 3 is a tryptophan residue…
Assignees
Inventors
Classifications
- C07K14/245Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9012152B2 cover?
- Isolated peptides comprising no more than ten amino acids and having anti-bacterial properties are disclosed. In one embodiment the peptides have a consensus amino acid sequence X 1 X 2 X 3 X 4 X 5 , wherein X 1 and X 5 comprise polar amino acids. In another embodiment, the peptides have a consensus amino acid sequence X 1 X 2 X 3 X 4 X 5 , wherein X 2 and X 4 are asparagine (N) residues an…
- Who is the assignee on this patent?
- Engelberg-Kulka Hanna, Kolodkin-Gal Ilana, Yissum Res Dev Co
- What technology area does this patent fall under?
- Primary CPC classification C07K14/245. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).